State Street Corp Catalyst Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 5,685,330 shares of CPRX stock, worth $129 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,685,330

Previous 6,033,298 5.77%

Holding current value

$129 Million

Previous $93.5 Million 20.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.19 - $21.35 $5.29 Million - $7.43 Million	-347,968 Reduced 5.77%	5,685,330 $113 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $31.1 Million - $35.9 Million	-2,119,604 Reduced 26.0%	6,033,298 $93.5 Million
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $18 Million - $23.4 Million	1,365,570 Added 20.12%	8,152,902 $130 Million
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $9.23 Million - $13.5 Million	-783,363 Reduced 10.35%	6,787,332 $114 Million
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $22 Million - $28.3 Million	-1,882,382 Reduced 19.91%	7,570,695 $88.5 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $22 Million - $34.5 Million	1,910,359 Added 25.33%	9,453,077 $127 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $4.74 Million - $6.96 Million	-330,596 Reduced 4.2%	7,542,718 $125 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $3.89 Million - $6.2 Million	317,891 Added 4.21%	7,873,314 $146 Million
Q3 2022 Nov 15, 2022	BUY	$7.06 - $15.52 $15 Million - $32.9 Million	2,117,944 Added 38.95%	7,555,423 $96.9 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $5.11 Million - $7.02 Million	819,524 Added 17.75%	5,437,479 $38.1 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $2.3 Million - $3.6 Million	-433,034 Reduced 8.57%	4,617,955 $38.3 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $5.31 Million - $7.59 Million	-1,018,392 Reduced 16.78%	5,050,989 $34.2 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $344,025 - $428,435	70,933 Added 1.18%	6,069,381 $32.2 Million
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $12.6 Million - $17.8 Million	-2,935,535 Reduced 32.86%	5,998,448 $34.5 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $4.69 $9.73 Million - $13.2 Million	2,820,053 Added 46.13%	8,933,983 $41.2 Million
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $4.51 Million - $5.82 Million	-1,518,422 Reduced 19.89%	6,113,930 $20.4 Million
Q3 2020 Nov 10, 2020	BUY	$2.97 - $5.08 $2.84 Million - $4.86 Million	955,751 Added 14.31%	7,632,352 $22.7 Million
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $2.66 Million - $3.86 Million	-764,221 Reduced 10.27%	6,676,601 $30.8 Million
Q1 2020 May 11, 2020	BUY	$2.61 - $5.21 $19.4 Million - $38.8 Million	7,440,822 New	7,440,822 $28.6 Million

Others Institutions Holding CPRX

# of Institutions

327

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Catalyst Pharmaceuticals, Inc. Transaction History